Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CLEC7A |
| Upstream (Parents) |
|---|
| (<<) CD53 → CLEC7A |
| (<<) CD86 → CLEC7A |
| Downstream (Children) |
|---|
| CLEC7A → TRPV2 (>>) |
| CLEC7A → LSP1 (>>) |
| CLEC7A → EPYC (>>) |
| CLEC7A → FGFR4 (>>) |
| CLEC7A → ADAM28 (>>) |
| CLEC7A → STK32B (>>) |
| CLEC7A → RSAD2 (>>) |
| CLEC7A → PTAFR (>>) |
| CLEC7A → CCL22 (>>) |
| CLEC7A → RHOH (>>) |
| CLEC7A → HPGDS (>>) |
| CLEC7A → KCNQ1 (>>) |
| CLEC7A → PTPN7 (>>) |
| CLEC7A → IFI16 (>>) |
| CLEC7A → RAC2 (>>) |
| CLEC7A → CLEC4A (>>) |
| CLEC7A → MAPK14 (>>) |
| CLEC7A → MNDA (>>) |
| CLEC7A → PIK3CD (>>) |
| CLEC7A → HS3ST3A1 (>>) |
| CLEC7A → EVI2B///EVI2A (>>) |
| CLEC7A → WIPF1 (>>) |
| CLEC7A → SYBU (>>) |
| CLEC7A → HCK (>>) |
